Article
Monrovia, CA—STAAR Surgical Co. has received approval from the Canadian Therapeutic Products Directorate to market its Visian Toric lens (TICL) in Canada.
Monrovia, CA-STAAR Surgical Co. has received approval from the Canadian Therapeutic Products Directorate to market its Visian Toric lens (TICL) in Canada. The posterior chamber phakic IOL corrects myopia and astigmatism without tissue removal, according to the company.
The Korean Food and Drug Administration, of South Korea, gave its approval to market the lens May 19.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.